Annual review of PROTAC degraders as anticancer agents in 2022.
Wang X, Qin ZL, Li N, Jia MQ, Liu QG, Bai YR, Song J, Yuan S, Zhang SY.
Wang X, et al. Among authors: liu qg.
Eur J Med Chem. 2024 Mar 5;267:116166. doi: 10.1016/j.ejmech.2024.116166. Epub 2024 Jan 25.
Eur J Med Chem. 2024.
PMID: 38281455
Review.